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SocietyI have read with interest the article by Loughlin et al., ‘‘The
CALM1 core promoter polymorphism is not associated
with hip osteoarthritis in a United Kingdom Caucasian popu-
lation.’’1 This work was a response to the identiﬁcation of this
gene in Japanese patients with hip osteoarthritis (OA)2. Both
studies contribute to our knowledge of the genetic basis of
different types of hip OA and raise issues of population dif-
ferences in this disease.
Mototani et al. have shown with a high degree of certainty
that the promoter polymorphism in CALM1 is associated
with Japanese hip OA but could not be found by the Oxford
group in Caucasians with hip OA. The best explanation for
this careful molecular work is a difference in the hip pheno-
types in the two populations. The UK Caucasians with hip
OA are well characterized as primary or idiopathic OA in
which they have excluded secondary OA due to congenital
hip-developmental dysplasia. In contrast, the Japanese
refer to Nakamura et al.3 for knowledge of Japanese hip
OA who found less than 1% primary OA in 2000 Japanese
patients with hip disease. Approximately 78e88% of Japa-
nese hip OA patients are due to congenital hip dislocations
or developmental acetabular dysplasia1,4. References in
the medical literature to treatment of Japanese hip OA
usually refer to congenital hip disease and not primary hip
OA.
In the current Japanese molecular study, over 90% of pa-
tients were female with a mean age 10 years younger than
the UK Caucasians, which is a classic proﬁle distribution for
a congenital disease of the hip (CDH) series. They reported
only 40% with acetabular dysplasia but did not record other
criteria for CDH3 in the remainder. When the Japanese hip
OA patients were stratiﬁed with and without acetabular dys-
plasia both groups had comparable rates of CALM1 pro-
moter gene polymorphisms which is consistent with
reported clinical series showing CDH as almost the only
hip disease causing hip OA in Japan.
Loughlin’s group by proving a genetic molecular differ-
ence between primary hip OA and the CDH of the Japanese
has indirectly established the CALM1 promoter polymor-
phism to be associated with Japanese congenital hip
disease. Although the clinical presentation of CDH in the
Japanese seems more severe than Caucasian CDH, the
phenotype (hip dysplasia without other skeletal ﬁndings)
suggests a genetic basis common to both ethnic groups.
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6503425164; E-mail: fhoaglund@comcast.net59Other populations with a high incidence of CDH, the North
American native people, i.e., the Navaho5 or the northern
Italian would provide interesting studies for comparison.
The identiﬁcation of a gene for a disease like CDH has
the expected beneﬁts of identifying the degree of genetic
risk, correlating with possible environmental causative
factors and providing a target for speciﬁc pharmacologic
prevention or treatment. A gene for CDH would have the ad-
ditional beneﬁt of providing some answers to longstanding
arguments of minor degrees of dysplasia and anatomical
factors causing or contributing to late onset (idiopathic or
primary) hip OA.
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